NFKB1 and neoplasm: It should be notice that PHY906 could inhibit intestine inflammation triggered by CPT11 by inhibiting many inflammation pathways including NF-κB, COX2 and iNOS6 while PHY906 could converse tumor inflammation from chronic status to acute status associated with strong macrophage infiltration following CPT-118 and Sorafenib treatment.